US44930G1076 - Common Stock
ICU MEDICAL INC
NASDAQ:ICUI (4/19/2024, 7:00:02 PM)
After market: 95.77 0 (0%)95.77
-1.13 (-1.17%)
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 14,500 full-time employees. The Company’s product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its primary Infusion System products are dedicated IV sets and others. Its primary IV Solutions products include IV Therapy and Diluents and Irrigation. Its primary Critical Care products include Cogent 2-in-1 hemodynamic monitoring system; CardioFlo hemodynamic monitoring system; TDQ and OptiQ cardiac output monitoring catheters; TriOxTM venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation system.
ICU MEDICAL INC
951 Calle Amanecer
San Clemente CALIFORNIA 92763
P: 19493662183
CEO: Vivek Jain
Employees: 14500
Website: https://www.icumed.com/
SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative...
SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative...
SAN CLEMENTE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative...
Here you can normally see the latest stock twits on ICUI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: